Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States

A retrospective cohort analysis of the US MarketScan claims databases was performed to compare persistence and discontinuation rates between the vitamin K antagonist warfarin and the non-vitamin K antagonist oral anticoagulants rivaroxaban and dabigatran in patients with non-valvular atrial fibrilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Craig I., Tangirala, Muralikrishna, Evers, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915663/
https://www.ncbi.nlm.nih.gov/pubmed/27327275
http://dx.doi.org/10.1371/journal.pone.0157769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915663/
https://www.ncbi.nlm.nih.gov/pubmed/27327275
http://dx.doi.org/10.1371/journal.pone.0157769

Ejemplares similares